Welcome members and clients of OMMP PIF. Due to increased costs, our website has moved to this server, Thanks go to our Friend and colleague, Wired57, for making this possible. If you have any questions or concerns, please start a new topic in 
Thank you 
10-25-2014, 09:45 AM
Cannabinoids: The Future of Breast Cancer Therapy?October 22, 2014
Thanks to the technical discovery of the first cannabinoid-specific membrane receptor (CB1), which was characterized back in 1988 and then cloned in 1990, we now have scientific evidence suggesting that cannabinoid-based medicines may be valuable for the treatment of most breast tumor subtypes.
Sadly so, breast cancer is a widespread disease that affects roughly 1 in 10 women at some point throughout their life, raising great need for new strategies to combat the potentially deadly malady.
Although some drug developers have seen significant success with their medicines, certain breast tumors are opposed to the usual therapies offered by Western medicine, resulting in relapse for a sizeable amount of breast cancer patients.
So whats the answer? Is it marijuana?
Well, its quite plausible, especially when you take into consideration the number of scientific studies that has recently been conducted regarding the medicinal usefulness of cannabinoids as an anticancer agent.
In addition, we have an ample amount of experimental evidence thats been collected over the last decade or so supporting that cannabinoids, the active compounds of the marijuana plant and their derivatives, do indeed possess anticancer action.
Cannabinoids are a family of exceptional compounds manufactured by the marijuana plant that have yet to be found in any other plant genus known to science.
Owed to its great quantity in the marijuana plant and its strong biological action, the main representative in the list of beneficial cannabinoids is delta-9-Tetrahydrocannabinol (THC).
But as of late, more studies are being conducted involving the isolation of certain cannabinoids in order to study their individual activity on specific cancers and other ailments...................
http://the420times.com/2014/10/cannabino...0+Times%29
Thanks to the technical discovery of the first cannabinoid-specific membrane receptor (CB1), which was characterized back in 1988 and then cloned in 1990, we now have scientific evidence suggesting that cannabinoid-based medicines may be valuable for the treatment of most breast tumor subtypes.
Sadly so, breast cancer is a widespread disease that affects roughly 1 in 10 women at some point throughout their life, raising great need for new strategies to combat the potentially deadly malady.
Although some drug developers have seen significant success with their medicines, certain breast tumors are opposed to the usual therapies offered by Western medicine, resulting in relapse for a sizeable amount of breast cancer patients.
So whats the answer? Is it marijuana?
Well, its quite plausible, especially when you take into consideration the number of scientific studies that has recently been conducted regarding the medicinal usefulness of cannabinoids as an anticancer agent.
In addition, we have an ample amount of experimental evidence thats been collected over the last decade or so supporting that cannabinoids, the active compounds of the marijuana plant and their derivatives, do indeed possess anticancer action.
Cannabinoids are a family of exceptional compounds manufactured by the marijuana plant that have yet to be found in any other plant genus known to science.
Owed to its great quantity in the marijuana plant and its strong biological action, the main representative in the list of beneficial cannabinoids is delta-9-Tetrahydrocannabinol (THC).
But as of late, more studies are being conducted involving the isolation of certain cannabinoids in order to study their individual activity on specific cancers and other ailments...................
http://the420times.com/2014/10/cannabino...0+Times%29